1. Home
  2. HOG vs DYN Comparison

HOG vs DYN Comparison

Compare HOG & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$29.32

Market Cap

2.9B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

SELL

Current Price

$16.91

Market Cap

2.8B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HOG
DYN
Founded
1903
1984
Country
United States
United States
Employees
6400
N/A
Industry
Motor Vehicles
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HOG
DYN
Price
$29.32
$16.91
Analyst Decision
Buy
Strong Buy
Analyst Count
15
17
Target Price
$28.10
★ $36.00
AVG Volume (30 Days)
1.9M
★ 2.9M
Earning Date
10-29-2026
11-09-2026
Dividend Yield
★ 2.55%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.97
N/A
Revenue
★ $4,473,175,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.80
N/A
P/E Ratio
$30.38
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$17.09
$14.00
52 Week High
$29.63
$27.31

Technical Indicators

Market Signals
Indicator
HOG
DYN
Relative Strength Index (RSI) 64.61 52.98
Support Level $26.35 $16.65
Resistance Level N/A $17.31
Average True Range (ATR) 0.88 0.88
MACD 0.27 0.40
Stochastic Oscillator 84.70 91.82

Price Performance

Historical Comparison
HOG
DYN

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: